Cases | Histol | Grade | FIGO Stage | Metast. Peri-tumor (%) | Metastatic LN (%)a | HPV-pos Peri-tumor (%) | HPV-pos LN (%) | HPVb | Recurrencec |
---|---|---|---|---|---|---|---|---|---|
SCC-04 | SCC | 3 | IB | 3/6 (50) | 0/4 - | 4/6 (66.6) | 2/4 (50) | HPV16 | Pelvic |
SCC-05 | SCC | 2 | IA | 0/2 - | 0/1 - | 0/2 - | 0/1 - | HPV18 | No |
SCC-07 | SCC | 3 | IIIB | 1/2 (50) | 0 - | 1/2 (50) | 0 - | HPV35 | Lung |
SCC-09 | SCC | 3 | IA | 0/4 - | 0/1 - | 0/4 - | 0/1 - | n/a | No |
SCC-12 | SCC | 2 | IIA | 0 - | 0/1 - | 0 - | 0/1 - | HPV16 | Pelvic/Lung |
SCC-20 | SCC | 3 | IA | 0/3 - | 0/2 - | 0/3 - | 0/2 - | n/a | No |
SCC-22 | SCC | 2 | IB | 0/2 - | 0/3 - | 1/2 (50) | 2/3 (66.6) | HPV45 | No |
SCC-24 | SCC | 1 | IB | 0/2 - | 0/6 - | 1/2 (50) | 5/6 (83.3) | HPV16 | n/a |
SCC-39 | SCC | 3 | IIB | 0 - | 1/4 (25) | 0 - | 3/4 (75) | HPV16 | Lung |
SCC-41 | SCC | 3 | IB | 0/3 - | 2/3 (66.6) | 1/3 (33.3) | 0/3 - | HPV66 | No |
SCC-42 | SCC | 2 | IA | 0 - | 0/3 - | 0 - | 0/3 - | n/a | No |
SCC-43 | SCC | 3 | IB | 0 - | 0/9 - | 0 - | 0/9 - | n/a | No |
SCC-44 | SCC | 3 | IB | 8/9 (88.8) | 0/6 - | 8/9 (88.8) | 6/6 (100) | HPV16 | n/a |
SCC-45 | SCC | 1 | IB | 11/11 (100) | 1/10 (10) | 11/11 (100) | 1/10 (10) | HPV16 | n/a |
SCC-46 | SCC | 3 | IB | 0 - | 0/8 - | 0 - | 0/8 - | HPV16 | n/a |
SCC-47 | SCC | 3 | IIB | 0 - | 0/2 - | 0 - | 0/2 - | HPV16 | Dead |
AC-10 | AC | 3 | IB | 0/5 - | 0/3 - | 1/5 (20) | 0/3 - | HPV16 | n/a |
AC-11 | AC | 2 | IIA | 0/1 - | 1/4 (25) | 0/1 - | 1/4 (25) | HPV18 | n/a |
AC-18 | AC | 3 | IB | 0/4 - | 0/2 - | 0/4 - | 0/2 - | n/a | No |
AC-19 | AC | 2 | IIA | 0 - | 0/1 - | 0 - | 0/1 - | HPV18 | Pelvic |